普通外文研报
Replay: Corporate Access: SAN C-Suite CFO call: Near-term momentum, but to address Dupi cliff, elevated and accelerated Business Development required
研报英文原文证据摘录
Replay: Corporate Access: SAN C-Suite CFO call: Near-term momentum, but to address Dupi cliff, elevated and accelerated Business Development required
Equity Research
18 June 2026
Replay: Corporate Access
SAN C-Suite CFO call: Near-term
momentum, but to address Dupi
cliff, elevated and accelerated European Pharmaceuticals,
Biotechnology & Life Sciences
James GordonBusiness Development required
+44 (0)20 7116 2784
james.gordon@barclays.comCFO Francois Roger noted in-house pipeline insufficient to
Barclays, UK
offset Dupixent LOE, hence accelerating/bigger BD/M&A
Yihan Li, PhD
needed, in addition to improved in-house R&D. New CEO +44 (0)20 3555 3563
Belen Garijo will provide update at Q2, further detail at Q3, yihan.li@barclays.com
tbd if event later in year. Sidhartha Modi
+91 (0)22 6175 1326
sidhartha.modi@barclays.com
Barclays, UK Please see below replay information for the event held on
Friday, 12 June 2026 at 2:00pm – 3:00pm London Charles Pitman-King, CFA
+44 (0)20 3134 6023
This replay is strictly and solely for the benefit of the intended recipients. Barclays Events Terms of charles.pitman-king@barclays.com
Service and the Barclays Events Privacy Notice Barclays, UK
Watch
This transcript/recording is provided in an unedited format. Barclays is not responsible for the
recording quality or any transcription errors or omissions.
Appearances by Third-Party Speakers: Any views or opinions expressed by third-party speakers
during this event are solely those of the speaker and do not represent the views or opinions of
Barclays. Barclays is not responsible for, and makes no warranties whatsoever as to, the
information or opinions contained in any written, electronic, audio or video presentations by any
third-party speakers at the event (“Third-Party Content”).
本摘录由系统从所标注的 PDF 证据页直接提取并保留英文原文,不做批量翻译;登录后在阅读器切换中文时才按需翻译。
打开研报阅读器